CNBX Pharmaceuticals Inc. (CNBX) Payables (2011 - 2026)
CNBX Pharmaceuticals' (CNBX) quarterly Payables came in at $165228.0 in Q2 2026, down 88.04% YoY from $1.4 million in Q2 2025, and up 39.4% on a QoQ basis from $118530.0 in Q1 2026.
CNBX Pharmaceuticals Inc. (CNBX) Payables (2011 - 2026) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 16 years of Payables data on file, last reported at $165228.0 in Q2 2026.
- Quarterly Payables fell 88.04% year-over-year to $165228.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $165228.0 (down 88.04% YoY) and the FY2025 annual result came in at $49252.0, down 96.31% from the prior year.
- Payables advanced to $165228.0 in Q2 2026, from $118530.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $1.7 million in Q3 2023 to a low of $49252.0 in Q3 2025.
- A 5-year average of $963367.3 and a median of $1.1 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables surged 258.94% — and 2025, when it plunged 96.31%.
- Tracing CNBX's Payables over 5 years: stood at $820558.0 in 2022, then jumped by 90.09% to $1.6 million in 2023, then slipped by 11.51% to $1.4 million in 2024, then retreated by 9.28% to $1.3 million in 2025, then plunged by 86.8% to $165228.0 in 2026.
- The last three Payables figures came in at $165228.0 (Q2 2026), $118530.0 (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 165,228.00 |
| Feb 28, 2026 | 118,530.00 |
| Nov 30, 2025 | 1.25 Mn |
| Aug 31, 2025 | 49,252.00 |
| May 31, 2025 | 1.38 Mn |
| Feb 28, 2025 | 1.46 Mn |
| Nov 30, 2024 | 1.38 Mn |
| Aug 31, 2024 | 1.34 Mn |
| May 31, 2024 | 1.48 Mn |
| Feb 29, 2024 | 1.52 Mn |
| Nov 30, 2023 | 1.56 Mn |
| Aug 31, 2023 | 1.68 Mn |
| May 31, 2023 | 1.02 Mn |
| Feb 28, 2023 | 424,580.00 |
| Nov 30, 2022 | 820,558.00 |
| Aug 31, 2022 | 684,773.00 |
| May 31, 2022 | 543,233.00 |
| Feb 28, 2022 | 460,838.00 |
| Nov 30, 2021 | 424,094.00 |
| Aug 31, 2021 | 401,150.00 |